CCL

Committee Verdict

The committee approves holding the CCL position at current 2.51% weight. Portfolio Analyst correctly identified that Q1 FY2026 operationally confirmed the thesis (EPS beat, yield guide RAISED to 2.75%, 85% booked, $2.5B buyback) while acknowledging the $500M fuel headwind forced an 11% FY EPS guidance cut. Risk Manager confirmed all constraints remain satisfied and recommended proceed. Devil's Advocate raised two high-severity concerns that merit explicit response: (1) the rally was largely fuel-relief-driven rather than pure operational validation — valid, but the independent strengthening of booking/yield/buyback pillars means the thesis did NOT rely solely on fuel; (2) multiple compression from 9x to 13x forward EPS has monetized most of the original margin of safety — acknowledged, which is why this is a hold and explicitly NOT an add. The Devil's Advocate's recommendation to trigger /update-thesis before any subsequent sizing decision is adopted as a monitoring trigger. Classification remains price-below-value for now, but the edge has narrowed materially and the next review must operate on refreshed predictions.

Despite real concerns, the thesis survives challenge because the operational pillars (bookings, yields, deleveraging, capital return) all strengthened simultaneously — the yield guide raise, 85% booked, and $2.5B buyback are independent confirmations that do not depend on the Iran narrative. The classification remains price-below-value even at $29.08 because 13x forward EPS on a business delivering 55% YoY net income growth with record booked position is not demanding. However, the challenge points are severe enough that the committee SHOULD formally trigger /update-thesis to refresh the edge computation on revised guidance, and should NOT add to the position at current levels. Hold is defensible; add would not be.